| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5582062 | Clinical Lymphoma Myeloma and Leukemia | 2017 | 23 Pages |
Abstract
Prolonged imatinib therapy helps to achieve a deeper molecular response in the long-term. Achieving deeper molecular response at any time positively affects maintaining the cytogenetic and molecular responses, and decreases the transformation to accelerated and/or blastic phase. The slight prolongation in PFS did not reach statistical significance.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Isik Kaygusuz Atagunduz, Tayfur Toptas, Rabia Deniz, Osman Kara, Ali Eser, Aslıhan Sezgin, Toluy Ozgumus, Fatma Gecgel, Tulin Firatli Tuglular,